Get started
Author

Janvier Serumondo

Observed names: J. Serumondo, Serumondo, Janvier, janvier serumondo
ORCID: 0000-0002-9373-0197
Observed ORCID: 0000-0002-9373-0197
OpenAlex ID: A5051247148
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
2024 · Alison D Marshall, Alex R Willing, et al. · ˜The œLancet. Gastroenterology & hepatology · 73
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda
2019 · Jean Damascene Makuza, Jean Olivier Twahirwa Rwema, et al. · BMC Infectious Diseases · 63
PDF
Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa
2019 · Grace Umutesi, Fabienne Shumbusho, et al. · Journal of Hepatology · 57
PDF
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
2019 · Jean Damascene Makuza, Carol Y. Liu, et al. · BMC Infectious Diseases · 31
PDF
Lessons Learned From Global Hepatitis C Elimination Programs
2023 · Senad Handanagic, Shaun Shadaker, et al. · The Journal of Infectious Diseases · 26
PDF
Innovative strategies for a successful SLMTA country programme: The Rwanda story
2014 · Innocent Nzabahimana, Sabin Sebasirimu, et al. · African Journal of Laboratory Medicine · 23
PDF
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study
2021 · Innocent Kamali, Dale A. Barnhart, et al. · PLoS ONE · 20
PDF
Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population
2019 · Justine Umutesi, Carol Yingkai Liu, et al. · BMJ Open · 19
PDF
Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial
2022 · Neil Gupta, Linda Manirambona, et al. · ˜The œLancet. Gastroenterology & hepatology · 18
The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign
2023 · Marie Paul Nisingizwe, Jean Damascene Makuza, et al. · Viruses · 17
PDF
Values and preferences for hepatitis C self-testing among the general population and healthcare workers in Rwanda
2021 · Janvier Serumondo, Sonjelle Shilton, et al. · BMC Infectious Diseases · 14
PDF
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach
2021 · Innocent Kamali, Dale A. Barnhart, et al. · BMC Infectious Diseases · 13
PDF
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial
2022 · Fredrick Kateera, Fabienne Shumbusho, et al. · ˜The œLancet. Gastroenterology & hepatology · 12
Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study
2020 · Jean Damascene Makuza, Marie Paul Nisingizwe, et al. · BMJ Open · 12
PDF
Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study
2022 · Innocent Kamali, Fabienne Shumbusho, et al. · BMC Infectious Diseases · 11
PDF
Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation
2024 · Huaiyang Zhong, Alec Aaron, et al. · Value in Health · 10
PDF
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators
2020 · Janvier Serumondo, Michael J. Penkunas, et al. · BMC Public Health · 10
PDF
Effectiveness of Direct-acting Antivirals for the Treatment of Chronic Hepatitis C in Rwanda: A Retrospective Study
2020 · Sabin Nsanzimana, Michael J Penkunas, et al. · Clinical Infectious Diseases · 10
Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study
2024 · Tumusime Musafiri, Innocent Kamali, et al. · BMC Infectious Diseases · 9
PDF
Epidemiology of sexually transmitted infections: trends among patients screened for sexually transmitted infections in rwandan health facilities 2014–2020
2022 · Jean Damascene Makuza, Phyumar Soe, et al. · BMC Infectious Diseases · 7
PDF
Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa
2023 · Justine Umutesi, Ming-Lung Yu, et al. · The Journal of Infectious Diseases · 6
Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda
2025 · Janvier Serumondo, Peter Barebwanuwe, et al. · Clinical Infectious Diseases · 4
Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa
2021 · Fabienne Shumbusho, Anne F. Liu, et al. · Journal of Viral Hepatitis · 4
Improved quality of life following direct‐acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub‐Saharan Africa (the SHARED study)
2020 · Jennifer Ilo Van Nuil, Grace Umutesi, et al. · Journal of Viral Hepatitis · 4
Hepatitis B Virus Care Cascade in Rwanda: A Population-based Study From 2016–2023
2025 · Jean Damascene Makuza, Dahn Jeong, et al. · Clinical Infectious Diseases · 3
Works count: 44
Citation count: 483
H-index: 12
I10-index: 18
Year
Topic
Type